ABBV Dec 2025 135.000 call
| Previous close | 50.65 |
| Open | 50.65 |
| Bid | 37.00 |
| Ask | 39.75 |
| Strike | 135.00 |
| Expiry date | 2025-12-19 |
| Day's range | 50.65 - 50.65 |
| Contract range | N/A |
| Volume | |
| Open interest | 95 |
ZacksEli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksGear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
PR NewswireAllergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is offering consumers an opportunity to be featured in upcoming campaigns for their biggest brands, including BOTOX® Cosmetic, the JUVÉDERM® Collection of Fillers, and Allē, the Allergan Aesthetics loyalty rewards program. Beginning today, consumers—including existing patients and those who are considering aesthetic treatment—can apply for a chance to be included in future brand campaigns. The first Allergan Aesthetics open casting call for BO
